nodes	percent_of_prediction	percent_of_DWPC	metapath
Ixabepilone—Microtubule Inhibition—Docetaxel—head and neck cancer	0.576	1	CiPCiCtD
Ixabepilone—TUBB2A—Vinblastine—head and neck cancer	0.0238	0.0641	CbGbCtD
Ixabepilone—TUBB6—Vinblastine—head and neck cancer	0.0238	0.0641	CbGbCtD
Ixabepilone—TUBB4A—Vinblastine—head and neck cancer	0.0238	0.0641	CbGbCtD
Ixabepilone—TUBB2B—Vinblastine—head and neck cancer	0.0238	0.0641	CbGbCtD
Ixabepilone—TUBB3—Vinblastine—head and neck cancer	0.0238	0.0641	CbGbCtD
Ixabepilone—TUBB8—Vinblastine—head and neck cancer	0.0238	0.0641	CbGbCtD
Ixabepilone—TUBB1—Vinblastine—head and neck cancer	0.0199	0.0537	CbGbCtD
Ixabepilone—TUBB4B—Vinblastine—head and neck cancer	0.0199	0.0537	CbGbCtD
Ixabepilone—TUBB—Vinblastine—head and neck cancer	0.0199	0.0537	CbGbCtD
Ixabepilone—TUBB8—Docetaxel—head and neck cancer	0.0196	0.0529	CbGbCtD
Ixabepilone—TUBB6—Docetaxel—head and neck cancer	0.0196	0.0529	CbGbCtD
Ixabepilone—TUBB2A—Docetaxel—head and neck cancer	0.0196	0.0529	CbGbCtD
Ixabepilone—TUBB2B—Docetaxel—head and neck cancer	0.0196	0.0529	CbGbCtD
Ixabepilone—TUBB4A—Docetaxel—head and neck cancer	0.0196	0.0529	CbGbCtD
Ixabepilone—TUBB3—Docetaxel—head and neck cancer	0.0196	0.0529	CbGbCtD
Ixabepilone—TUBB4B—Docetaxel—head and neck cancer	0.0164	0.0442	CbGbCtD
Ixabepilone—TUBB1—Docetaxel—head and neck cancer	0.0164	0.0442	CbGbCtD
Ixabepilone—TUBB—Docetaxel—head and neck cancer	0.0164	0.0442	CbGbCtD
Ixabepilone—Acute pulmonary oedema—Fluorouracil—head and neck cancer	0.00247	0.0597	CcSEcCtD
Ixabepilone—Neutropenic infection—Docetaxel—head and neck cancer	0.00233	0.0564	CcSEcCtD
Ixabepilone—Acute pulmonary oedema—Docetaxel—head and neck cancer	0.00178	0.0431	CcSEcCtD
Ixabepilone—Peripheral motor neuropathy—Docetaxel—head and neck cancer	0.00092	0.0223	CcSEcCtD
Ixabepilone—CYP3A4—Vinblastine—head and neck cancer	0.00085	0.00229	CbGbCtD
Ixabepilone—Myelosuppression—Vinblastine—head and neck cancer	0.000756	0.0183	CcSEcCtD
Ixabepilone—CYP3A4—Docetaxel—head and neck cancer	0.000701	0.00189	CbGbCtD
Ixabepilone—Myelosuppression—Hydroxyurea—head and neck cancer	0.00069	0.0167	CcSEcCtD
Ixabepilone—Enterocolitis—Docetaxel—head and neck cancer	0.000605	0.0146	CcSEcCtD
Ixabepilone—Mucosal inflammation—Hydroxyurea—head and neck cancer	0.000584	0.0141	CcSEcCtD
Ixabepilone—Skin hyperpigmentation—Hydroxyurea—head and neck cancer	0.000544	0.0132	CcSEcCtD
Ixabepilone—Dysaesthesia—Fluorouracil—head and neck cancer	0.000538	0.013	CcSEcCtD
Ixabepilone—Febrile neutropenia—Hydroxyurea—head and neck cancer	0.000538	0.013	CcSEcCtD
Ixabepilone—TUBB—hair follicle—head and neck cancer	0.000538	0.0495	CbGeAlD
Ixabepilone—Polyneuropathy—Docetaxel—head and neck cancer	0.000516	0.0125	CcSEcCtD
Ixabepilone—Ileus—Vinblastine—head and neck cancer	0.000501	0.0121	CcSEcCtD
Ixabepilone—Myelosuppression—Fluorouracil—head and neck cancer	0.000497	0.012	CcSEcCtD
Ixabepilone—Lower respiratory tract infection—Docetaxel—head and neck cancer	0.000492	0.0119	CcSEcCtD
Ixabepilone—Neuritis—Vinblastine—head and neck cancer	0.000475	0.0115	CcSEcCtD
Ixabepilone—TUBB3—connective tissue—head and neck cancer	0.000464	0.0428	CbGeAlD
Ixabepilone—TUBB4B—hair follicle—head and neck cancer	0.000458	0.0422	CbGeAlD
Ixabepilone—Cardiomyopathy—Fluorouracil—head and neck cancer	0.000455	0.011	CcSEcCtD
Ixabepilone—Atrial flutter—Docetaxel—head and neck cancer	0.000442	0.0107	CcSEcCtD
Ixabepilone—Neurotoxicity—Docetaxel—head and neck cancer	0.000433	0.0105	CcSEcCtD
Ixabepilone—TUBB8—head—head and neck cancer	0.000401	0.0369	CbGeAlD
Ixabepilone—Skin hyperpigmentation—Fluorouracil—head and neck cancer	0.000391	0.00947	CcSEcCtD
Ixabepilone—Dysaesthesia—Docetaxel—head and neck cancer	0.000389	0.0094	CcSEcCtD
Ixabepilone—Febrile neutropenia—Fluorouracil—head and neck cancer	0.000387	0.00936	CcSEcCtD
Ixabepilone—Nail disorder—Fluorouracil—head and neck cancer	0.000359	0.00868	CcSEcCtD
Ixabepilone—Myelosuppression—Docetaxel—head and neck cancer	0.000358	0.00867	CcSEcCtD
Ixabepilone—TUBB3—lymphoid tissue—head and neck cancer	0.00034	0.0313	CbGeAlD
Ixabepilone—Lymphopenia—Docetaxel—head and neck cancer	0.000328	0.00794	CcSEcCtD
Ixabepilone—TUBB2B—parotid gland—head and neck cancer	0.00031	0.0286	CbGeAlD
Ixabepilone—Skin exfoliation—Hydroxyurea—head and neck cancer	0.000309	0.00747	CcSEcCtD
Ixabepilone—Mucosal inflammation—Docetaxel—head and neck cancer	0.000304	0.00734	CcSEcCtD
Ixabepilone—TUBB2B—saliva-secreting gland—head and neck cancer	0.000297	0.0274	CbGeAlD
Ixabepilone—TUBB—parotid gland—head and neck cancer	0.000294	0.027	CbGeAlD
Ixabepilone—TUBB2A—parotid gland—head and neck cancer	0.000292	0.0269	CbGeAlD
Ixabepilone—Myocardial ischaemia—Fluorouracil—head and neck cancer	0.00029	0.00701	CcSEcCtD
Ixabepilone—TUBB6—parotid gland—head and neck cancer	0.000288	0.0265	CbGeAlD
Ixabepilone—TUBB4A—connective tissue—head and neck cancer	0.000283	0.026	CbGeAlD
Ixabepilone—Skin hyperpigmentation—Docetaxel—head and neck cancer	0.000283	0.00683	CcSEcCtD
Ixabepilone—TUBB—saliva-secreting gland—head and neck cancer	0.000281	0.0259	CbGeAlD
Ixabepilone—TUBB2A—saliva-secreting gland—head and neck cancer	0.00028	0.0258	CbGeAlD
Ixabepilone—Febrile neutropenia—Docetaxel—head and neck cancer	0.000279	0.00676	CcSEcCtD
Ixabepilone—TUBB6—saliva-secreting gland—head and neck cancer	0.000276	0.0254	CbGeAlD
Ixabepilone—TUBB3—head—head and neck cancer	0.000274	0.0252	CbGeAlD
Ixabepilone—TUBB2B—connective tissue—head and neck cancer	0.000273	0.0251	CbGeAlD
Ixabepilone—TUBB1—head—head and neck cancer	0.000268	0.0246	CbGeAlD
Ixabepilone—Embolism—Docetaxel—head and neck cancer	0.000262	0.00633	CcSEcCtD
Ixabepilone—Nail disorder—Docetaxel—head and neck cancer	0.000259	0.00627	CcSEcCtD
Ixabepilone—TUBB2A—connective tissue—head and neck cancer	0.000257	0.0237	CbGeAlD
Ixabepilone—Lacrimation increased—Fluorouracil—head and neck cancer	0.000253	0.00611	CcSEcCtD
Ixabepilone—TUBB4B—parotid gland—head and neck cancer	0.00025	0.0231	CbGeAlD
Ixabepilone—Pharyngolaryngeal pain—Docetaxel—head and neck cancer	0.000249	0.00602	CcSEcCtD
Ixabepilone—Laryngeal pain—Docetaxel—head and neck cancer	0.000247	0.00596	CcSEcCtD
Ixabepilone—Neuralgia—Docetaxel—head and neck cancer	0.000242	0.00585	CcSEcCtD
Ixabepilone—Burning sensation—Docetaxel—head and neck cancer	0.000242	0.00585	CcSEcCtD
Ixabepilone—TUBB6—epithelium—head and neck cancer	0.000241	0.0222	CbGeAlD
Ixabepilone—TUBB4B—saliva-secreting gland—head and neck cancer	0.00024	0.0221	CbGeAlD
Ixabepilone—Ileus—Docetaxel—head and neck cancer	0.000237	0.00574	CcSEcCtD
Ixabepilone—TUBB2B—trachea—head and neck cancer	0.000229	0.0211	CbGeAlD
Ixabepilone—Neuritis—Docetaxel—head and neck cancer	0.000225	0.00544	CcSEcCtD
Ixabepilone—TUBB4B—connective tissue—head and neck cancer	0.00022	0.0203	CbGeAlD
Ixabepilone—TUBB—trachea—head and neck cancer	0.000217	0.02	CbGeAlD
Ixabepilone—Angina pectoris—Vinblastine—head and neck cancer	0.000217	0.00524	CcSEcCtD
Ixabepilone—TUBB2A—trachea—head and neck cancer	0.000216	0.0199	CbGeAlD
Ixabepilone—TUBB6—trachea—head and neck cancer	0.000213	0.0196	CbGeAlD
Ixabepilone—Oesophagitis—Fluorouracil—head and neck cancer	0.000213	0.00515	CcSEcCtD
Ixabepilone—Pancytopenia—Vinblastine—head and neck cancer	0.000211	0.00511	CcSEcCtD
Ixabepilone—Myocardial ischaemia—Docetaxel—head and neck cancer	0.000209	0.00506	CcSEcCtD
Ixabepilone—TUBB4A—lymphoid tissue—head and neck cancer	0.000207	0.019	CbGeAlD
Ixabepilone—Sepsis—Fluorouracil—head and neck cancer	0.000202	0.00489	CcSEcCtD
Ixabepilone—Acute coronary syndrome—Vinblastine—head and neck cancer	0.000196	0.00473	CcSEcCtD
Ixabepilone—Neuropathy peripheral—Vinblastine—head and neck cancer	0.000194	0.0047	CcSEcCtD
Ixabepilone—Myocardial infarction—Vinblastine—head and neck cancer	0.000194	0.0047	CcSEcCtD
Ixabepilone—Pancytopenia—Hydroxyurea—head and neck cancer	0.000193	0.00466	CcSEcCtD
Ixabepilone—Neutropenia—Hydroxyurea—head and neck cancer	0.00019	0.00459	CcSEcCtD
Ixabepilone—TUBB4A—thyroid gland—head and neck cancer	0.000188	0.0173	CbGeAlD
Ixabepilone—Bone disorder—Docetaxel—head and neck cancer	0.000186	0.0045	CcSEcCtD
Ixabepilone—TUBB6—lymphoid tissue—head and neck cancer	0.000185	0.0171	CbGeAlD
Ixabepilone—TUBB4B—trachea—head and neck cancer	0.000185	0.017	CbGeAlD
Ixabepilone—Lacrimation increased—Docetaxel—head and neck cancer	0.000182	0.00441	CcSEcCtD
Ixabepilone—TUBB2B—thyroid gland—head and neck cancer	0.000181	0.0167	CbGeAlD
Ixabepilone—Infestation—Hydroxyurea—head and neck cancer	0.000181	0.00438	CcSEcCtD
Ixabepilone—Infestation NOS—Hydroxyurea—head and neck cancer	0.000181	0.00438	CcSEcCtD
Ixabepilone—Haemoglobin—Vinblastine—head and neck cancer	0.000179	0.00433	CcSEcCtD
Ixabepilone—Haemorrhage—Vinblastine—head and neck cancer	0.000178	0.00431	CcSEcCtD
Ixabepilone—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.000177	0.00429	CcSEcCtD
Ixabepilone—Hypoaesthesia—Vinblastine—head and neck cancer	0.000177	0.00429	CcSEcCtD
Ixabepilone—Stomatitis—Hydroxyurea—head and neck cancer	0.000176	0.00427	CcSEcCtD
Ixabepilone—Lethargy—Fluorouracil—head and neck cancer	0.000172	0.00417	CcSEcCtD
Ixabepilone—TUBB—thyroid gland—head and neck cancer	0.000172	0.0158	CbGeAlD
Ixabepilone—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.000171	0.00414	CcSEcCtD
Ixabepilone—Respiratory failure—Docetaxel—head and neck cancer	0.000171	0.00414	CcSEcCtD
Ixabepilone—TUBB2A—thyroid gland—head and neck cancer	0.000171	0.0157	CbGeAlD
Ixabepilone—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.000169	0.00409	CcSEcCtD
Ixabepilone—TUBB6—thyroid gland—head and neck cancer	0.000168	0.0155	CbGeAlD
Ixabepilone—TUBB4A—head—head and neck cancer	0.000167	0.0153	CbGeAlD
Ixabepilone—Haemoglobin—Hydroxyurea—head and neck cancer	0.000163	0.00395	CcSEcCtD
Ixabepilone—Haemorrhage—Hydroxyurea—head and neck cancer	0.000162	0.00393	CcSEcCtD
Ixabepilone—Colitis—Docetaxel—head and neck cancer	0.000161	0.0039	CcSEcCtD
Ixabepilone—TUBB4B—lymphoid tissue—head and neck cancer	0.000161	0.0148	CbGeAlD
Ixabepilone—TUBB2B—head—head and neck cancer	0.000161	0.0148	CbGeAlD
Ixabepilone—Skin exfoliation—Docetaxel—head and neck cancer	0.00016	0.00388	CcSEcCtD
Ixabepilone—Neuropathy—Docetaxel—head and neck cancer	0.000158	0.00382	CcSEcCtD
Ixabepilone—Alopecia—Vinblastine—head and neck cancer	0.000157	0.00381	CcSEcCtD
Ixabepilone—Oesophagitis—Docetaxel—head and neck cancer	0.000154	0.00371	CcSEcCtD
Ixabepilone—TUBB2A—head—head and neck cancer	0.000151	0.0139	CbGeAlD
Ixabepilone—TUBB6—head—head and neck cancer	0.000149	0.0138	CbGeAlD
Ixabepilone—Muscular weakness—Fluorouracil—head and neck cancer	0.000149	0.00361	CcSEcCtD
Ixabepilone—Angiopathy—Hydroxyurea—head and neck cancer	0.000147	0.00356	CcSEcCtD
Ixabepilone—TUBB4B—thyroid gland—head and neck cancer	0.000146	0.0135	CbGeAlD
Ixabepilone—Dysphagia—Fluorouracil—head and neck cancer	0.000146	0.00353	CcSEcCtD
Ixabepilone—Sepsis—Docetaxel—head and neck cancer	0.000146	0.00353	CcSEcCtD
Ixabepilone—Chills—Hydroxyurea—head and neck cancer	0.000146	0.00353	CcSEcCtD
Ixabepilone—Alopecia—Hydroxyurea—head and neck cancer	0.000144	0.00347	CcSEcCtD
Ixabepilone—Anaemia—Vinblastine—head and neck cancer	0.000143	0.00347	CcSEcCtD
Ixabepilone—Angina pectoris—Fluorouracil—head and neck cancer	0.000142	0.00344	CcSEcCtD
Ixabepilone—Leukopenia—Vinblastine—head and neck cancer	0.000139	0.00336	CcSEcCtD
Ixabepilone—Pancytopenia—Fluorouracil—head and neck cancer	0.000139	0.00336	CcSEcCtD
Ixabepilone—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.000136	0.00328	CcSEcCtD
Ixabepilone—Pneumonia—Fluorouracil—head and neck cancer	0.000131	0.00317	CcSEcCtD
Ixabepilone—Anaemia—Hydroxyurea—head and neck cancer	0.000131	0.00316	CcSEcCtD
Ixabepilone—Hot flush—Docetaxel—head and neck cancer	0.00013	0.00315	CcSEcCtD
Ixabepilone—Infestation NOS—Fluorouracil—head and neck cancer	0.00013	0.00315	CcSEcCtD
Ixabepilone—Infestation—Fluorouracil—head and neck cancer	0.00013	0.00315	CcSEcCtD
Ixabepilone—TUBB4B—head—head and neck cancer	0.00013	0.012	CbGeAlD
Ixabepilone—Menopausal symptoms—Docetaxel—head and neck cancer	0.000129	0.00313	CcSEcCtD
Ixabepilone—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.000128	0.00311	CcSEcCtD
Ixabepilone—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000128	0.00309	CcSEcCtD
Ixabepilone—Myocardial infarction—Fluorouracil—head and neck cancer	0.000128	0.00309	CcSEcCtD
Ixabepilone—Stomatitis—Fluorouracil—head and neck cancer	0.000127	0.00307	CcSEcCtD
Ixabepilone—Urinary tract infection—Fluorouracil—head and neck cancer	0.000127	0.00306	CcSEcCtD
Ixabepilone—Leukopenia—Hydroxyurea—head and neck cancer	0.000127	0.00306	CcSEcCtD
Ixabepilone—Lethargy—Docetaxel—head and neck cancer	0.000124	0.00301	CcSEcCtD
Ixabepilone—Thrombocytopenia—Vinblastine—head and neck cancer	0.000124	0.003	CcSEcCtD
Ixabepilone—Hyponatraemia—Docetaxel—head and neck cancer	0.000122	0.00296	CcSEcCtD
Ixabepilone—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.000122	0.00295	CcSEcCtD
Ixabepilone—Anorexia—Vinblastine—head and neck cancer	0.000121	0.00292	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00012	0.00289	CcSEcCtD
Ixabepilone—Haemoglobin—Fluorouracil—head and neck cancer	0.000118	0.00284	CcSEcCtD
Ixabepilone—Haemorrhage—Fluorouracil—head and neck cancer	0.000117	0.00283	CcSEcCtD
Ixabepilone—TUBB4A—lymph node—head and neck cancer	0.000117	0.0107	CbGeAlD
Ixabepilone—Hypoaesthesia—Fluorouracil—head and neck cancer	0.000116	0.00281	CcSEcCtD
Ixabepilone—Oedema—Hydroxyurea—head and neck cancer	0.000115	0.00279	CcSEcCtD
Ixabepilone—Infection—Hydroxyurea—head and neck cancer	0.000115	0.00277	CcSEcCtD
Ixabepilone—Paraesthesia—Vinblastine—head and neck cancer	0.000114	0.00275	CcSEcCtD
Ixabepilone—Dehydration—Docetaxel—head and neck cancer	0.000113	0.00274	CcSEcCtD
Ixabepilone—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000113	0.00274	CcSEcCtD
Ixabepilone—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000113	0.00273	CcSEcCtD
Ixabepilone—TUBB2B—lymph node—head and neck cancer	0.000113	0.0104	CbGeAlD
Ixabepilone—Skin disorder—Hydroxyurea—head and neck cancer	0.000112	0.00271	CcSEcCtD
Ixabepilone—Anorexia—Hydroxyurea—head and neck cancer	0.00011	0.00266	CcSEcCtD
Ixabepilone—Decreased appetite—Vinblastine—head and neck cancer	0.00011	0.00266	CcSEcCtD
Ixabepilone—Pain—Vinblastine—head and neck cancer	0.000108	0.00262	CcSEcCtD
Ixabepilone—Constipation—Vinblastine—head and neck cancer	0.000108	0.00262	CcSEcCtD
Ixabepilone—TUBB—lymph node—head and neck cancer	0.000107	0.00982	CbGeAlD
Ixabepilone—TUBB2A—lymph node—head and neck cancer	0.000106	0.00977	CbGeAlD
Ixabepilone—Dysphagia—Docetaxel—head and neck cancer	0.000105	0.00255	CcSEcCtD
Ixabepilone—TUBB6—lymph node—head and neck cancer	0.000105	0.00963	CbGeAlD
Ixabepilone—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000103	0.0025	CcSEcCtD
Ixabepilone—Alopecia—Fluorouracil—head and neck cancer	0.000103	0.0025	CcSEcCtD
Ixabepilone—Dyspnoea—Hydroxyurea—head and neck cancer	0.000103	0.00249	CcSEcCtD
Ixabepilone—Angina pectoris—Docetaxel—head and neck cancer	0.000103	0.00248	CcSEcCtD
Ixabepilone—Decreased appetite—Hydroxyurea—head and neck cancer	0.0001	0.00243	CcSEcCtD
Ixabepilone—Pancytopenia—Docetaxel—head and neck cancer	0.0001	0.00242	CcSEcCtD
Ixabepilone—Abdominal pain—Vinblastine—head and neck cancer	0.0001	0.00242	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	9.96e-05	0.00241	CcSEcCtD
Ixabepilone—Fatigue—Hydroxyurea—head and neck cancer	9.95e-05	0.00241	CcSEcCtD
Ixabepilone—Pain—Hydroxyurea—head and neck cancer	9.87e-05	0.00239	CcSEcCtD
Ixabepilone—Constipation—Hydroxyurea—head and neck cancer	9.87e-05	0.00239	CcSEcCtD
Ixabepilone—Neutropenia—Docetaxel—head and neck cancer	9.86e-05	0.00238	CcSEcCtD
Ixabepilone—Weight decreased—Docetaxel—head and neck cancer	9.54e-05	0.00231	CcSEcCtD
Ixabepilone—Pneumonia—Docetaxel—head and neck cancer	9.46e-05	0.00229	CcSEcCtD
Ixabepilone—Anaemia—Fluorouracil—head and neck cancer	9.41e-05	0.00228	CcSEcCtD
Ixabepilone—Infestation NOS—Docetaxel—head and neck cancer	9.4e-05	0.00227	CcSEcCtD
Ixabepilone—Infestation—Docetaxel—head and neck cancer	9.4e-05	0.00227	CcSEcCtD
Ixabepilone—Hypersensitivity—Vinblastine—head and neck cancer	9.32e-05	0.00226	CcSEcCtD
Ixabepilone—Acute coronary syndrome—Docetaxel—head and neck cancer	9.27e-05	0.00224	CcSEcCtD
Ixabepilone—Renal failure—Docetaxel—head and neck cancer	9.24e-05	0.00224	CcSEcCtD
Ixabepilone—Neuropathy peripheral—Docetaxel—head and neck cancer	9.21e-05	0.00223	CcSEcCtD
Ixabepilone—Myocardial infarction—Docetaxel—head and neck cancer	9.21e-05	0.00223	CcSEcCtD
Ixabepilone—Jaundice—Docetaxel—head and neck cancer	9.16e-05	0.00222	CcSEcCtD
Ixabepilone—Stomatitis—Docetaxel—head and neck cancer	9.16e-05	0.00222	CcSEcCtD
Ixabepilone—Body temperature increased—Hydroxyurea—head and neck cancer	9.12e-05	0.00221	CcSEcCtD
Ixabepilone—Leukopenia—Fluorouracil—head and neck cancer	9.11e-05	0.0022	CcSEcCtD
Ixabepilone—TUBB4B—lymph node—head and neck cancer	9.09e-05	0.00837	CbGeAlD
Ixabepilone—Asthenia—Vinblastine—head and neck cancer	9.08e-05	0.0022	CcSEcCtD
Ixabepilone—Hepatobiliary disease—Docetaxel—head and neck cancer	8.89e-05	0.00215	CcSEcCtD
Ixabepilone—Myalgia—Fluorouracil—head and neck cancer	8.67e-05	0.0021	CcSEcCtD
Ixabepilone—Chest pain—Fluorouracil—head and neck cancer	8.67e-05	0.0021	CcSEcCtD
Ixabepilone—Diarrhoea—Vinblastine—head and neck cancer	8.66e-05	0.00209	CcSEcCtD
Ixabepilone—Hypersensitivity—Hydroxyurea—head and neck cancer	8.5e-05	0.00206	CcSEcCtD
Ixabepilone—Haemoglobin—Docetaxel—head and neck cancer	8.48e-05	0.00205	CcSEcCtD
Ixabepilone—Haemorrhage—Docetaxel—head and neck cancer	8.44e-05	0.00204	CcSEcCtD
Ixabepilone—Hypoaesthesia—Docetaxel—head and neck cancer	8.4e-05	0.00203	CcSEcCtD
Ixabepilone—Dizziness—Vinblastine—head and neck cancer	8.37e-05	0.00202	CcSEcCtD
Ixabepilone—Urinary tract disorder—Docetaxel—head and neck cancer	8.33e-05	0.00202	CcSEcCtD
Ixabepilone—Oedema—Fluorouracil—head and neck cancer	8.31e-05	0.00201	CcSEcCtD
Ixabepilone—Connective tissue disorder—Docetaxel—head and neck cancer	8.29e-05	0.00201	CcSEcCtD
Ixabepilone—Asthenia—Hydroxyurea—head and neck cancer	8.28e-05	0.002	CcSEcCtD
Ixabepilone—Urethral disorder—Docetaxel—head and neck cancer	8.27e-05	0.002	CcSEcCtD
Ixabepilone—Infection—Fluorouracil—head and neck cancer	8.25e-05	0.002	CcSEcCtD
Ixabepilone—Nervous system disorder—Fluorouracil—head and neck cancer	8.15e-05	0.00197	CcSEcCtD
Ixabepilone—Thrombocytopenia—Fluorouracil—head and neck cancer	8.13e-05	0.00197	CcSEcCtD
Ixabepilone—Vomiting—Vinblastine—head and neck cancer	8.05e-05	0.00195	CcSEcCtD
Ixabepilone—Erythema multiforme—Docetaxel—head and neck cancer	7.98e-05	0.00193	CcSEcCtD
Ixabepilone—Headache—Vinblastine—head and neck cancer	7.93e-05	0.00192	CcSEcCtD
Ixabepilone—Anorexia—Fluorouracil—head and neck cancer	7.92e-05	0.00192	CcSEcCtD
Ixabepilone—Diarrhoea—Hydroxyurea—head and neck cancer	7.9e-05	0.00191	CcSEcCtD
Ixabepilone—Eye disorder—Docetaxel—head and neck cancer	7.89e-05	0.00191	CcSEcCtD
Ixabepilone—Cardiac disorder—Docetaxel—head and neck cancer	7.83e-05	0.00189	CcSEcCtD
Ixabepilone—Hypotension—Fluorouracil—head and neck cancer	7.76e-05	0.00188	CcSEcCtD
Ixabepilone—Angiopathy—Docetaxel—head and neck cancer	7.66e-05	0.00185	CcSEcCtD
Ixabepilone—Dizziness—Hydroxyurea—head and neck cancer	7.63e-05	0.00185	CcSEcCtD
Ixabepilone—Immune system disorder—Docetaxel—head and neck cancer	7.62e-05	0.00184	CcSEcCtD
Ixabepilone—Mediastinal disorder—Docetaxel—head and neck cancer	7.61e-05	0.00184	CcSEcCtD
Ixabepilone—Chills—Docetaxel—head and neck cancer	7.57e-05	0.00183	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	7.57e-05	0.00183	CcSEcCtD
Ixabepilone—Nausea—Vinblastine—head and neck cancer	7.52e-05	0.00182	CcSEcCtD
Ixabepilone—Insomnia—Fluorouracil—head and neck cancer	7.51e-05	0.00182	CcSEcCtD
Ixabepilone—Paraesthesia—Fluorouracil—head and neck cancer	7.46e-05	0.0018	CcSEcCtD
Ixabepilone—Alopecia—Docetaxel—head and neck cancer	7.46e-05	0.0018	CcSEcCtD
Ixabepilone—Dyspnoea—Fluorouracil—head and neck cancer	7.41e-05	0.00179	CcSEcCtD
Ixabepilone—Mental disorder—Docetaxel—head and neck cancer	7.39e-05	0.00179	CcSEcCtD
Ixabepilone—Malnutrition—Docetaxel—head and neck cancer	7.35e-05	0.00178	CcSEcCtD
Ixabepilone—Vomiting—Hydroxyurea—head and neck cancer	7.34e-05	0.00177	CcSEcCtD
Ixabepilone—Rash—Hydroxyurea—head and neck cancer	7.28e-05	0.00176	CcSEcCtD
Ixabepilone—Dermatitis—Hydroxyurea—head and neck cancer	7.27e-05	0.00176	CcSEcCtD
Ixabepilone—Headache—Hydroxyurea—head and neck cancer	7.23e-05	0.00175	CcSEcCtD
Ixabepilone—Decreased appetite—Fluorouracil—head and neck cancer	7.22e-05	0.00175	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Fluorouracil—head and neck cancer	7.17e-05	0.00173	CcSEcCtD
Ixabepilone—Pain—Fluorouracil—head and neck cancer	7.1e-05	0.00172	CcSEcCtD
Ixabepilone—Muscle spasms—Docetaxel—head and neck cancer	7.06e-05	0.00171	CcSEcCtD
Ixabepilone—Nausea—Hydroxyurea—head and neck cancer	6.85e-05	0.00166	CcSEcCtD
Ixabepilone—Anaemia—Docetaxel—head and neck cancer	6.79e-05	0.00164	CcSEcCtD
Ixabepilone—Syncope—Docetaxel—head and neck cancer	6.59e-05	0.00159	CcSEcCtD
Ixabepilone—Leukopenia—Docetaxel—head and neck cancer	6.58e-05	0.00159	CcSEcCtD
Ixabepilone—Body temperature increased—Fluorouracil—head and neck cancer	6.57e-05	0.00159	CcSEcCtD
Ixabepilone—Loss of consciousness—Docetaxel—head and neck cancer	6.46e-05	0.00156	CcSEcCtD
Ixabepilone—Cough—Docetaxel—head and neck cancer	6.41e-05	0.00155	CcSEcCtD
Ixabepilone—Arthralgia—Docetaxel—head and neck cancer	6.25e-05	0.00151	CcSEcCtD
Ixabepilone—Chest pain—Docetaxel—head and neck cancer	6.25e-05	0.00151	CcSEcCtD
Ixabepilone—Myalgia—Docetaxel—head and neck cancer	6.25e-05	0.00151	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	6.21e-05	0.0015	CcSEcCtD
Ixabepilone—Hypersensitivity—Fluorouracil—head and neck cancer	6.12e-05	0.00148	CcSEcCtD
Ixabepilone—Oedema—Docetaxel—head and neck cancer	6e-05	0.00145	CcSEcCtD
Ixabepilone—Infection—Docetaxel—head and neck cancer	5.96e-05	0.00144	CcSEcCtD
Ixabepilone—Shock—Docetaxel—head and neck cancer	5.9e-05	0.00143	CcSEcCtD
Ixabepilone—Nervous system disorder—Docetaxel—head and neck cancer	5.88e-05	0.00142	CcSEcCtD
Ixabepilone—Pruritus—Fluorouracil—head and neck cancer	5.88e-05	0.00142	CcSEcCtD
Ixabepilone—Thrombocytopenia—Docetaxel—head and neck cancer	5.87e-05	0.00142	CcSEcCtD
Ixabepilone—Skin disorder—Docetaxel—head and neck cancer	5.82e-05	0.00141	CcSEcCtD
Ixabepilone—Anorexia—Docetaxel—head and neck cancer	5.72e-05	0.00138	CcSEcCtD
Ixabepilone—Diarrhoea—Fluorouracil—head and neck cancer	5.68e-05	0.00137	CcSEcCtD
Ixabepilone—Hypotension—Docetaxel—head and neck cancer	5.6e-05	0.00136	CcSEcCtD
Ixabepilone—Dizziness—Fluorouracil—head and neck cancer	5.49e-05	0.00133	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Docetaxel—head and neck cancer	5.46e-05	0.00132	CcSEcCtD
Ixabepilone—Insomnia—Docetaxel—head and neck cancer	5.42e-05	0.00131	CcSEcCtD
Ixabepilone—Paraesthesia—Docetaxel—head and neck cancer	5.38e-05	0.0013	CcSEcCtD
Ixabepilone—Dyspnoea—Docetaxel—head and neck cancer	5.35e-05	0.00129	CcSEcCtD
Ixabepilone—Vomiting—Fluorouracil—head and neck cancer	5.28e-05	0.00128	CcSEcCtD
Ixabepilone—Rash—Fluorouracil—head and neck cancer	5.24e-05	0.00127	CcSEcCtD
Ixabepilone—Dermatitis—Fluorouracil—head and neck cancer	5.23e-05	0.00127	CcSEcCtD
Ixabepilone—Decreased appetite—Docetaxel—head and neck cancer	5.21e-05	0.00126	CcSEcCtD
Ixabepilone—Headache—Fluorouracil—head and neck cancer	5.2e-05	0.00126	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Docetaxel—head and neck cancer	5.18e-05	0.00125	CcSEcCtD
Ixabepilone—Fatigue—Docetaxel—head and neck cancer	5.17e-05	0.00125	CcSEcCtD
Ixabepilone—Constipation—Docetaxel—head and neck cancer	5.13e-05	0.00124	CcSEcCtD
Ixabepilone—Pain—Docetaxel—head and neck cancer	5.13e-05	0.00124	CcSEcCtD
Ixabepilone—Nausea—Fluorouracil—head and neck cancer	4.93e-05	0.00119	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Docetaxel—head and neck cancer	4.9e-05	0.00119	CcSEcCtD
Ixabepilone—Body temperature increased—Docetaxel—head and neck cancer	4.74e-05	0.00115	CcSEcCtD
Ixabepilone—Abdominal pain—Docetaxel—head and neck cancer	4.74e-05	0.00115	CcSEcCtD
Ixabepilone—Hypersensitivity—Docetaxel—head and neck cancer	4.42e-05	0.00107	CcSEcCtD
Ixabepilone—Asthenia—Docetaxel—head and neck cancer	4.3e-05	0.00104	CcSEcCtD
Ixabepilone—Pruritus—Docetaxel—head and neck cancer	4.24e-05	0.00103	CcSEcCtD
Ixabepilone—Diarrhoea—Docetaxel—head and neck cancer	4.1e-05	0.000992	CcSEcCtD
Ixabepilone—Dizziness—Docetaxel—head and neck cancer	3.96e-05	0.000959	CcSEcCtD
Ixabepilone—Vomiting—Docetaxel—head and neck cancer	3.81e-05	0.000922	CcSEcCtD
Ixabepilone—Rash—Docetaxel—head and neck cancer	3.78e-05	0.000914	CcSEcCtD
Ixabepilone—Dermatitis—Docetaxel—head and neck cancer	3.78e-05	0.000914	CcSEcCtD
Ixabepilone—Headache—Docetaxel—head and neck cancer	3.76e-05	0.000909	CcSEcCtD
Ixabepilone—Nausea—Docetaxel—head and neck cancer	3.56e-05	0.000861	CcSEcCtD
